Abstract
The level of serum glycoproteins and their glycosylation pattern change in liver diseases including hepatocellular carcinoma (HCC). Some of them, especially alpha fetoprotein (AFP), serve as useful biomarkers for HCC. The present investigation showed high level of AFP in hepatitis B cirrhosis (HBV-LC) and hepatitis C cirrhosis (HCV-LC) patients. However, increase of AFP level was not significantly high in chronic hepatitis B (HBV-CH) as determined by ELISA using monoclonal anti-human AFP (mAb-AFP). The differential expression of sialic acid linkage was observed in HBV-CH and HCV-LC by ELISA; the former bound strongly with Sambucus nigra agglutinin (SNA), which has exclusive binding specificity for NeuAcα2-6-, whereas HCV-LC reacted preferably with Maackia amurensis agglutinin (MAA) which recognizes NeuAcα2-3-. There was significantly high glycan branching in HBV-LC and HCV-LC in comparison to controls as illustrated by concanavalin A. This was further confirmed by Phaseolus vulgaris erythroagglutinin (E-PHA) and Datura stramonium agglutinin (DSA). Enhanced fucosylation of AFP was observed in HBV-LC, HCV-LC and HCC patients by ELISA using fucose binding Aleuria aurantia lectin; however, maximum binding was found in HCC. Fucosylation with α1-6 linkage was further confirmed by Lens culinaris agglutinin (LCA). From the above results it is concluded that the changes in concentration of AFP, differential expression of sialic acid, increase of glycan branching and fucosylation have a prognostic value of hepatitis and it could be possible that lectin-based assay with AFP can aid in diagnosis of hepatitis diseases besides clinical examination and routine laboratory investigation.
Similar content being viewed by others
Abbreviations
- AFP:
-
Alpha-fetoprotein
- AGP:
-
Alpha1- acid glycoprotein
- ALL:
-
Aleuria aurantia lectin
- AST:
-
Aspartate aminotransferase
- ALT:
-
Alanine aminotransferase
- ALP:
-
Alkaline phosphatase
- ConA:
-
Concanavalin A
- HBV-CH:
-
Chronic hepatitis B
- HBV-LC:
-
Hepatitis B cirrhosis
- HCV-LC:
-
Hepatitis C cirrhosis
- MAA:
-
Maackia amurensis agglutinin
- SNA:
-
Sambucus nigra agglutinin
- Tf:
-
Transferrin
References
Fattovich, G., Stroffolini, T., Zagni, I., Donato, F.: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterol. 127, S35–50 (2004)
Sheth, S.G., Flamm, S.L., Gordon, F.D., Chopra, S.: AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 93, 44–48 (1998)
Williams, A.L., Hoofnagle, J.H.: Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterol. 95, 734–739 (1988)
Turner, G.A.: N-glycosylation of serum proteins in disease and its investigation using lectins. Clin. Chim. Acta 208, 149–171 (1992)
Biou, D., Wieruszeski, J.M., Konan, D., Fournet, B., Durand, G.: Hyperfucosylation of α1-acid glycoprotein during cirrhosis. Prog. Clin. Biol. Res. 300, 215–218 (1989)
Thompson, S., Matta, K.L., Turner, G.A.: Changes in fucose metabolism associated with heavy drinking and smoking: a preliminary report. Clin. Chim. Acta 201, 59–64 (1991)
Mann, A.C., Record, C.O., Self, C.H., Turner, G.A.: Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. Clin. Chim. Acta 227, 69–78 (1994)
Kondo, M., Hada, T., Fukui, K., Iwasaki, A., Higashino, K., Yasukawa, K.: Enzyme-linked immunosorbent assay (ELISA) for Aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis. Clin. Chim. Acta 243, 1–9 (1995)
Hada, T., Kondo, M., Yasukawa, K., Amuro, Y., Higashino, K.: Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein. Clin. Chim. Acta 281, 37–46 (1999)
Mondal, G., Chatterjee, U., Das, H.R., Chatterjee, B.P.: Enhanced expression of α1-acid glycorptein and fucosylation in hepatitis B patients provides an insight into pathogenesis. Glycoconj. J. 26, 1225–1234 (2009)
Crandall, B.F.: Alpha-fetoprotein: a review. CRC Crit. Rev. Clin. Lab. Sci. 15, 127–185 (1981)
Mizejewski, G.J.: New insights into AFP structure and function: potential biomedical applications. In: Mizejewski, G.J., Porter, I.H. (eds.) Alpha-fetoprotein and congenital disorders, pp. 5–34. Academic, Orlando (1985)
Deutsch, H.F.: Chemistry and biology of α-fetoprotein. Adv. Cancer Res. 56, 253–312 (1991)
Gitlin, D., Perricelli, A., Gitlin, G.M.: Synthesis of AFP by liver, yolk sac and GI tract of the human conception. Cancer Res. 32, 979–982 (1972)
Gitlin, D.: Normal biology of α fetoprotein. Ann. NY Acad. Sci. 259, 7–16 (1975)
Ball, D., Rose, E., Alpert, E.: Alpha-fetoprotein levels in normal adults. Am. J. Med. Sci. 303, 157–159 (1992)
Sizaret, P., Martel, N., Tuyns, A., Reynaud, S.: Mean alpha-fetoprotein values of 1, 333 males over 15 years by age groups. Digestion. 15, 97–103 (1977)
Aoyagi, Y., Suzuki, Y., Isemura, M., Soga, K., Ozaki, T., Ichida, T., Inoue, K., Sasaki, H., Ichida, F.: Differential reactivity of α-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma. Gann 75, 809–815 (1984)
Chan, D.W., Miao, Y.C.: Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure and application to cancer patients. Clin. Chem. 32, 2143–2146 (1986)
Breborowicz, J., Mackiewicz, A., Breborowicz, D.: Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin afftno-electrophoresis. Scand. J. Immunol. 14, 15–20 (1981)
Buamah, P.K., Cornell, C., Cassells-Smith, A.J., Skillen, A.W.: Differential reactivity of α-fetoprotein with lectins and its usefulness in the diagnosis of various liver diseases. Clin. Chim. Acta 168, 69–73 (1987)
Toftager-Larsen, K., Peterson, P.L., Norgood-Pedersen, B.: Carbohydrate heterogeneity of human alpha-fetoprotein: oncodevelopmental aspects. In: Bog-Hanson, T.C. (ed.) Lectins-biology, biochemistry, clinical biochemistry, vol. 1, pp. 283–292. Walter de Gruyter, Berlin (1981)
Ishiguro, T., Sakaguchi, H., Fukui, M.: Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E. Jpn J. Surg. 16, 16–21 (1986)
Buamah, P.K., Gibb, I., Bates, G., Mitford, W.A.: Serum alpha fetoprotein heterogeneity as a means of differentiation between primary hepatocellular carcinoma and hepatic secondaries. Clin. Chim. Acta 139, 313–316 (1984)
Green, E.D., Baenziger, J.U.: Characterization of oligosaccharides by lectin affinity high-performance liquid chromatography. Trends Biochem. Sci. 14, 168–172 (1989)
Ishibashi, K., Nishikawa, A., Hayashi, N., Kasahara, A., Sato, N., Fujii, S., Kamada, T., Taniguchi, N.: N-Acetylglucosaminyltransferase in human serum and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients. Clin. Chim. Acta 185, 325–332 (1989)
Miyoshi, E., Noda, K., Yamaguchi, Y., Inoue, S., Ikeda, Y., Wang, W., Ko, J.H., Uozumi, N., Li, W., Taniguchi, N.: The α 1-6-fucosyltransferase gene and its biological significance. Biochim. Biophys. Acta 1473, 9–20 (1999)
Breborowicz, J., Mackiewicz, A., Breborowicz, D.: Microheterogeneity of α-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand. J. Immunol. 14, 15–20 (1981)
Miyazaki, J., Endo, Y., Oda, T.: Lectin affinities of α-fetoprotein in liver cirrhosis, hepatocellular carcinoma and metastatic liver tumor. Acta Hepatol. Jpn. 22, 1559–1568 (1981)
Kornfeld, S., Reitman, M.L., Kornfeld, R.: The carbohydrate binding specificity of pea and lentil lectins. J. Biol. Chem. 256, 6633–6640 (1981)
Taketa, K., Ichikawa, E., Taga, H., Hirai, H.: Antibody-affinity blotting, a sensitive technique for the detection of α-fetoprotein separated by lectin affinity electrophoresis in agarose gels. Electrophoresis 6, 492–497 (1985)
Taketa, K.: A tetrazolium method for peroxidase staining; application to the antibody-affinity blotting of α-fetoprotein in cancer diagnosis. Electrophoresis 8, 409–414 (1987)
Aoyagi, Y., Isemura, Y., Yoshizawa, Z., Suzuki, Y., Sekine, C., Ono, T., Ichida, F.: Fucosylation of serum α-fetoprotein with primary hepatocellular carcinoma. Biochim. Biophys. Acta 830, 217–223 (1985)
Suzuki, Y., Aoyagi, Y., Muramatsu, M., Sekine, C., Isemura, M., Ichida, F.: Close topographical relationship in α-fetoprotein (AFP) between a Lens culinaris binding glycan and the epitope recognized by AFP-reactive monoclonal antibody, 18H4. Br. J. Cancer 55, 147–152 (1987)
Aoyagi, Y., Suzuki, Y., Igarashi, K., Saitoh, A., Oguro, M., Yokota, T., Mori, S., Nomoto, M., Isemura, M., Asakura, H.: The usefulness of simultaneous determinations of glucosaminylation and fucosylation induces of α-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 67, 2390–2394 (1991)
Taketa, K., Sekiya, C., Namiki, M., Akamatsu, K., Ohta, Y., Endo, Y., Kosaka, K.: Lectin-reactive profiles of α-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterol. 99, 508–518 (1990)
Taketa, K., Endo, Y., Sekiya, C., Tanikawa, K., Taga, H., Satomura, S., Matsuura, S., Kawai, T., Hirai, H.: A collaborative study for the evaluation of lectin-reactive α-fetoprotein in early detection of hepatocellular carcinoma. Cancer Res. 53, 5419–5423 (1993)
Sato, Y., Nakata, K., Kato, Y., Shima, M., Ishii, N., Koji, T., Taketa, K., Endo, Y., Nagataki, S.: Early recognition of hepatocellular carcinoma based on altered profiles of α-fetoprotein. N. Engl. J. Med. 328, 1802–1806 (1993)
Shiraki, K., Takase, K., Tameda, Y., Hamada, M., Kosaka, Y., Nakano, T.: A clinical study of lectin-reactive α -fetoprotein as an early indicator of hepatocellular carcinoma in the follow- up of cirrhotic patients. Hepatology 22, 802–807 (1995)
Yamashita, F., Tanaka, M., Satomura, S., Tanikawa, K.: Prognostic significance of Lens culinaris agglutinin-reactive α-fetoprotein in small hepatocellular carcinomas. Gastroenterol. 111, 996–1001 (1996)
Aoyagi, Y., Isokawa, O., Suda, T., Watanabe, M., Suzuki, Y., Asakura, H.: The fucosylation index of α-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer 83, 2076–2082 (1998)
Ajdukiewicz, A.B., Kelleher, P.C., Krawittb, E.L., Waltersc, C.J.P., Masonc, P.B., Koffd, R.S., Bilanger, L.: α-Fetoprotein glycosylation is abnormal in some hepatocellular carcinomas, including white patients with a normal α -fetoprotein concentration. Cancer Lett. 74, 43–50 (1993)
Di Bisceglie, A.M.: Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection. Med. Clin. North Am. 73, 985–997 (1989)
Block, T.M., Mehta, A.S., Fimmel, C.J., Jordan, R.: Molecular viral oncology of hepatocellular carcinoma. Oncogene 22, 5093–5107 (2003)
Marrero, J.A.: Hepatocellular carcinoma. Curr. Opin. Gastroenterol. 22, 248–253 (2006)
Sallie, R., Di Bisceglie, A.M.: Viral hepatitis and hepatocellular carcinoma. Gastroenterol. Clin. North Am. 23, 567–579 (1994)
Lok, A., McMahon, B.: Chronic hepatitis B. Hepatology 34, 1225–1241 (2001)
El Serag, H.B., Mason, A.C., Key, C.: Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 33, 62–65 (2001)
Sarbah, S.A., Gramlich, T., Younoszai, A., Osmack, P., Goormastic, M., Grosso, L., Cooper, J.N., Di Bisceglie, A., Seneca, R., Younossi, Z.M.: Risk factors for hepatocellular carcinoma in patients with cirrhosis. Dig. Dis. Sci. 49, 850–853 (2004)
Jezequel, M., Seta, N.S., Corbic, M.M., Jeanne, M.F., Genevieve, M.D.: Modifications of Concanavalin A patterns of α1 acid glycoprotein and α-2-HS glycoprotein in alcoholic liver disease. Clin. Chim. Acta 176, 49–57 (1988)
Spik, G., Debruyne, V., Montreuil, J.: Alterations of the carbohydrate structure of human serotransferrin in liver diseases. In: Popper, H., Reutter, W. (eds.) Structural carbohydrates in the liver, pp. 477–483. MTP, Basel (1983)
Hachulla, E., Laine, A., Hendouin, V., Fournier, C., Maury, F., Mathieu, C., Pruvot, F.R., Declerck, N., Paris, J.C., Degand, P.: Variations in the glycoforms of serum α-antichymotrypsin in liver diseases and after liver transplantation. Clin. Sci. 82, 439–446 (1992)
Acknowledgements
This study was financially supported by a research grant (BT/PR4462/BRB/10/350/2003) from Department of Biotechology, Government of India, New Delhi to B.P.C. The authors thank sincerely Mr. Suneel Arora, Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh for collection of the serum samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mondal, G., Chatterjee, U., Chawla, Y.K. et al. Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients. Glycoconj J 28, 1–9 (2011). https://doi.org/10.1007/s10719-010-9316-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-010-9316-z